Ji Xia

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Journal: Journal for immunotherapy of cancer
Published: July 19, 2025

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

Journal: Oncogene
Published: July 26, 2023

RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.

RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.

Journal: Journal of translational medicine
Published: April 15, 2023

XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

Journal: The Journal of cell biology
Published: March 03, 2023

PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1.

PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 28, 2022

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1.

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1.

Journal: Cell reports
Published: April 18, 2022

ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2.

ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2.

Journal: Cell death and differentiation
Published: April 08, 2022

PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

Journal: Oncogene
Published: January 31, 2022

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis.

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis.

Journal: Toxins
Published: October 13, 2021

Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.

Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.

Journal: Cellular and molecular gastroenterology and hepatology
Published: September 27, 2021

Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.

Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.

Journal: Oncogene
Published: April 02, 2021

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.

Journal: Nature communications
Published: June 12, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026